Pharmacy Times
JUNE 20, 2025
Blood cancer patients are usually at higher risk due to prior chemotherapy, and maybe we don’t need the same kind of prophylactic medications for solid tumor patients. I think we’re getting to the point now where hematology and oncology both need services that can manage these types of side effects. The infection risks are a little different.
Pharmacy Times
JUNE 23, 2025
“This act…allowed a pathway for manufacturers to create a ‘copy’ of a licensed patent product to make it cheaper and more discounted,” Soefje, director of pharmacy cancer care services and associate professor of pharmacy at Mayo Clinic in Rochester, Minnesota, said at the HOPA conference.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
JUNE 9, 2025
Tichy, PharmD, MBA, vice chair of pharmacy formulary for Mayo Clinic, explained. Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. This governance issue is a very hot topic,” Eric M. Subscribe Now!
Pharmacy Times
JULY 14, 2025
TRE-515 Combined With a Radiopharmaceutical As a precision cancer treatment designed for adults with PSMA-positive mCRPC, lutetium Lu 177 vipivotide tetraxetan is used after individuals have undergone other treatments like androgen receptor pathway inhibition and taxane-based chemotherapy. Mayo Clinic. News release.
Pharmacy Times
JUNE 19, 2025
1 Biomarker testing is relatively new in the treatment landscape for NSCLC but has proven incredibly important for personalizing patient care, transforming from a generic chemotherapy approach to a highly personalized, genomically driven treatment strategy. For advanced disease, chemotherapy was the standard.
European Pharmaceutical Review
APRIL 7, 2023
A new, sustained-release chemotherapy delivery device inserted into the bladder, facilitated tumour response, a study has reported. The intravesical device, TAR-200, provides continuous, low-dose, local delivery of gemcitabine chemotherapy. In these patients, no evidence of bladder cancer was found at the follow-up.
Pharmaceutical Technology
MARCH 14, 2023
Platinum-based cancer drug compositions is a key innovation area in chemotherapy Platinum-based drugs are chemotherapeutic agents used for the treatment of cancer. Several platinum-based drugs such as cisplatin, carboplatin and oxaliplatin are widely used in cancer therapy.
Expert insights. Personalized for you.
26 
Let's personalize your content